Albisetti, M., Schlosser, A., Brueckmann, M., Gropper, S., Glund, S., Tartakovsky, I., . . . Reilly, P. A. (2017). Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. Res Pract Thromb Haemost.
Chicago-стиль цитированияAlbisetti, Manuela, Arno Schlosser, Martina Brueckmann, Savion Gropper, Stephan Glund, Igor Tartakovsky, Leonardo R. Brandão, and Paul A. Reilly. "Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for Venous Thromboembolism." Res Pract Thromb Haemost 2017.
MLA-цитированиеAlbisetti, Manuela, et al. "Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for Venous Thromboembolism." Res Pract Thromb Haemost 2017.